Potential Uses of Hemoglobin-based Oxygen Carriers in Critical Care Medicine

Critical Care Clinics

Volumn 25, Issue 2, 2009, Pages 311-324

  Creteur, Jacques ^a   Vincent, Jean Louis ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Nitric oxide; Oncotic pressure; Oxygen transport; Perioperative blood loss; Red blood cell; Sepsis; Transfusion; Trauma

Indexed keywords

ARTIFICIAL BLOOD; DIASPIRIN CROSSLINKED HEMOGLOBIN; HEMOGLOBIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; POLYMERIZED HEMOGLOBIN; SANGART; UNCLASSIFIED DRUG;

BLEEDING; BLOOD SUBSTITUTION; BLOOD TRANSFUSION; CLINICAL TRIAL; DISEASE TRANSMISSION; ERYTHROCYTE CONCENTRATE; HEART INFARCTION; HUMAN; IMMUNOGENICITY; INFECTION RISK; INJURY; INTENSIVE CARE; JEHOVAH'S WITNESS; NONHUMAN; ONCOTIC PRESSURE; OXYGEN AFFINITY; OXYGEN TRANSPORT; PERIOPERATIVE COMPLICATION; PRESSOR RESPONSE; PRIORITY JOURNAL; REVIEW; SEPSIS; SEPTIC SHOCK; SICKLE CELL ANEMIA; STROKE;

BIOLOGICAL TRANSPORT; BLOOD SUBSTITUTES; CRITICAL CARE; ERYTHROCYTE TRANSFUSION; HEMOGLOBINS; HUMANS; OXYGEN;

EID: 63149199557     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccc.2008.12.011     Document Type: Review

References (92)

1. Winslow R.M. Blood substitutes: refocusing an elusive goal. Br J Haematol 111 (2000) 387-396
2. Wagner P.D. An integrated view of the determinants of maximum oxygen uptake. In: Gonzales N.C., and Fredde M.R. (Eds). Oxygen transfer from atmosphere to tissues (1988), Plenum, New York 245-256
3. De Backer D., Creteur J., Preiser J.C., et al. Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med 166 (2002) 98-104
4. Vlahakes G.J., Lee R., Jacobs E.E., et al. Hemodynamic effects and oxygen transport properties of a new blood substitute in a model of massive blood replacement. J Thorac Cardiovasc Surg 100 (1990) 379-388
5. Przybelski R.J., Malcolm D.S., Burris D.G., et al. Cross-linked hemoglobin solution as a resuscitative fluid after hemorrhage in the rat. J Lab Clin Med 117 (1991) 143-151
6. Cohn S.M., and Farrell T.J. Diaspirin cross-linked hemoglobin resuscitation of hemorrhage: comparison of a blood substitute with hypertonic saline and isotonic saline. J Trauma 39 (1994) 210-217
7. Lee R., Neya K., Svizzero T.A., et al. Limitations of the efficacy of hemoglobin-based oxygen-carrying solutions. J Appl Physiol 79 (1995) 236-242
8. Leppäniemi A., Soltero R., Burris D., et al. Early resuscitation with low-volume poly-DCLHb is effective in the treatment of shock induced by penetrating vascular injury. J Trauma 40 (1996) 242-248
9. Hughes Jr. G.S., Antal E.J., Locker P.K., et al. Physiology and pharmacokinetics of a novel hemoglobin-based oxygen carrier in humans. Crit Care Med 24 (1996) 756-764
10. 2 carriers after 2h of hemorrhagic shock in conscious hamsters. Am J Physiol 272 (1997) H525-H537
11. Migita R., Gonzales A., Gonzales M.L., et al. Blood volume and cardiac index in rats after exchange transfusion with hemoglobin-based oxygen carriers. J Appl Physiol 82 (1997) 1995-2002
12. Cole D.J., Drummond J.C., Patel P.M., et al. Effect of oncotic pressure of diaspirin cross-linked hemoglobin (DCLHb) on brain injury after temporary focal cerebral ischemia in rats. Anesth Analg 83 (1996) 342-347
13. Intaglietta M., Johnson P.C., and Winslow R.M. Microvascular and tissue oxygen distribution. Cardiovasc Res 32 (1996) 632-643
14. Kuchan M.J., and Frangos J.A. Shear stress regulates endothelin-1 release via protein kinase C and cGMP in cultured endothelial cells. Am J Physiol 264 (1993) H150-H156
15. Kuchan M.J., Jo H., and Frangos J.A. Role of G proteins in shear stress-mediated nitric oxide production by endothelial cells. Am J Physiol 267 (1994) C753-C758
16. Tsai A.G., Friesenecker B., McCarthy M., et al. Plasma viscosity regulates capillary perfusion during extreme hemodilution in hamster skinfold model. Am J Physiol 275 (1998) H2170-H2180
17. Thompson A., McGarry A.E., Valeri C.R., et al. Stroma-free hemoglobin increases blood pressure and GFR in the hypotensive rat: role of nitric oxide. J Appl Physiol 77 (1994) 2348-2354
18. Sharma A.C., and Gulati A. Effect of diaspirin cross-linked hemoglobin and norepinephrine on systemic hemodynamics and regional circulation in rats. J Lab Clin Med 123 (1994) 299-308
19. Sharma A.C., Singh G., and Gulati A. Role of NO mechanism in cardiovascular effects of diaspirin cross-linked hemoglobin in anesthetized rats. Am J Physiol 269 (1995) H1379-H1388
20. Hindman B.J., Dexter F., Cutkomp J., et al. Diaspirin cross-linked hemoglobin dos not increase brain oxygen consumption during hypothermic cardiopulmonary bypass in rabbits. Anesthesiology 83 (1995) 1302-1311
21. Aranow J.S., Wang H., Zhuang J., et al. Effect of human hemoglobin on systemic and regional hemodynamics in a porcine model of endotoxemic shock. Crit Care Med 24 (1996) 807-814
22. Gulati A., Sharma A.C., and Singh G. Role of endothelin in the cardiovascular effects of diaspirin crosslinked and stroma reduced hemoglobin. Crit Care Med 24 (1996) 137-147
23. Kasper S.M., Grune F., Walter M., et al. The effects of increased doses of bovine hemoglobin on hemodynamics and oxygen transport in patients undergoing preoperative hemodilution for elective abdominal aortic surgery. Anesth Analg 87 (1998) 284-291
24. Przybelski R.J., Daily E.K., Kisicki J.C., et al. Phase I study of the safety and pharmacologic effects of diaspirin cross-linked hemoglobin solution. Crit Care Med 24 (1996) 1993-2000
25. Reah G., Bodenham A.R., Mallick A., et al. Initial evaluation of diaspirin cross-linked hemoglobin (DCLHb) as a vasopressor in critically ill patients. Crit Care Med 25 (1997) 1480-1488
26. Lamy M.L., Daily E.K., Brichant J.F., et al. Randomized trial of diaspirin cross-linked hemoglobin solution as an alternative to blood transfusion after cardiac surgery. Anesthesiology 92 (2000) 646-656
27. Hill S.E., Gottschalk L.I., and Grichnik K. Safety and preliminary efficacy of hemoglobin raffimer for patients undergoing coronary artery bypass surgery. J Cardiothorac Vasc Anesth 16 (2002) 695-702
28. Levy J.H., Goodnough L.T., Greilich P.E., et al. Polymerized bovine hemoglobin solution as a replacement for allogeneic red blood cell transfusion after cardiac surgery: results of a randomized, double-blind trial. J Thorac Cardiovasc Surg 124 (2002) 35-42
29. LaMuraglia G.M., O'Hara P.J., Baker W.H., et al. The reduction of the allogenic transfusion requirement in aortic surgery with a hemoglobin-based solution. J Vasc Surg 31 (2000) 299-308
30. Rooney M.W., Hirsch L.J., and Mathru M. Hemodilution with oxyhemoglobin: mechanism of oxygen deivery and its superaugmentation with a nitric oxide donor (sodium nitroprusside). Anesthesiology 79 (1993) 60-72
31. Schultz S.C., Grady B., Cole F., et al. A role for endothelin and nitric oxide in the pressor response to diaspirin cross-linked hemoglobin. J Lab Clin Med 122 (1993) 301-308
32. Freas W., Llave R., Jing M., et al. Contractile effects of diaspirin cross-linked hemoglobin (DCLHb) on isolated porcine blood vessels. J Lab Clin Med 125 (1995) 762-767
33. Ulatowski J.A., Nishikawa T., Matheson-Urbaitis B., et al. Regional blood flow alterations after bovine fumaryl ββ-crosslinked hemoglobin transfusion and nitric oxide synthase inhibition. Crit Care Med 24 (1996) 558-565
34. Hart J.L., Ledvina M.A., and Muldoon S.M. Actions of diaspirin cross-linked hemoglobin on isolated rat and dog vessels. J Lab Clin Med 129 (1997) 356-363
35. Resta T.C., Walker B.R., Eichinger M.R., et al. Rate of NO scavenging alters effects of recombinant hemoglobin solutions on pulmonary vasoreactivity. J Appl Physiol 93 (2002) 1327-1336
36. Rudolph A.S., Sulpizio A., Hieble P., et al. Liposome encapsulation attenuates hemoglobin-induced vasoconstriction in rabbit arterial segments. J Appl Physiol 82 (1997) 1826-1835
37. Bone H.G., Schenarts P.J., Booke M., et al. Oxalated pyridoxalated hemoglobin polyoxyethylene conjugate normalizes the hyperdynamic circulation in septic sheep. Crit Care Med 25 (1997) 1010-1018
38. Gulati A., Singh R., Chung S.M., et al. Role of endothelin-converting enzyme in the systemic hemodynamics and regional circulatory effects of proendothelin-1 (1-38) and diaspirin cross-linked hemoglobin in rats. J Lab Clin Med 126 (1995) 559-570
39. Rohlfs R.J., Bruner E., Chiu A., et al. Arterial blood pressure responses to cell-free hemoglobin solutions and the reaction with nitric oxide. J Biol Chem 273 (1998) 12128-12134
40. Sakai H., Hara H., Yuasa M., et al. Molecular dimensions of Hb-based O(2) carriers determine constriction of resistance arteries and hypertension. Am J Physiol Heart Circ Physiol 279 (2000) H908-H915
41. Bouwer S.T., Hoofd L., and Kreuzer F. Diffusion coefficients of oxygen and hemoglobin measured by facilitated oxygen diffusion through hemoglobin solutions. Biochim Biophys Acta 1338 (1997) 127-136
42. Nishide H., Chen X.S., and Tsuchida E. Facilitated oxygen transport with modified and encapsulated hemoglobins across non-flowing solution membrane. Artif Cells Blood Substit Immobil Biotechnol 25 (1997) 335-346
43. Lindbom L., Tuma R.F., and Arfors K.E. Influence of oxygen on perfused capillary density and capillary red cell velocity in rabbit skeletal muscle. Microvasc Res 19 (1980) 197-208
44. McCarthy M.R., Vandegriff K.D., and Winslow R.M. The role of facilitated diffusion in oxygen transport by cell-free hemoglobins: implications for the design of hemoglobin-based oxygen carriers. Biophys Chem 92 (2001) 103-117
45. Winslow R.M., Gonzales A., Gonzales M.L., et al. Vascular resistance and the efficacy of red cell substitutes in a rat hemorrhage model. J Appl Physiol 85 (1998) 993-1003
46. Wettstein R., Tsai A.G., Erni D., et al. Resuscitation with polyethylene glycol-modified human hemoglobin improves microcirculatory blood flow and tissue oxygenation after hemorrhagic shock in awake hamsters. Crit Care Med 31 (2003) 1824-1830
47. Gould S.A., Moore E.E., Hoyt D.B., et al. The first randomized trial of human polymerized hemoglobin as a blood substitute in acute trauma and emergent surgery. J Am Coll Surg 187 (1998) 113-120
48. Gould S.A., Moore E.E., Hoyt D.B., et al. The life-sustaining capacity of human polymerized hemoglobin when red cells might be unavailable. J Am Coll Surg 195 (2002) 445-452
49. Sloan E.P., Koenigsberg M., Gens D., et al. Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled efficacy trial. JAMA 282 (1999) 1857-1864
50. Kerner T., Ahlers O., Veit S., et al. DCL-Hb for trauma patients with severe hemorrhagic shock: the European On-Scene multicenter study. Intensive Care Med 29 (2003) 378-385
51. Northfield laboratories reports results of pivotal phase III trauma study [news release] (2007), Northfield Laboratories, Inc, Evanston (IL). Available at: http://phx.corporate-ir.net/phoenix.zhtml?c=91374&;p=irol-newsArticl e_print&ID=1005951&highlight= Accessed June 5, 2008
52. Schubert A., Przybelski R., Eidt J., et al. Diaspirin-crosslinked haemoglobin reduces blood transfusion in non cardiac surgery: a multicenter, randomized, controlled, double-blinded trial. Anesth Analg 97 (2003) 323-332
53. Cheng D., Mazer C., MArtineau R., et al. A phase II dose-response study of hemoglobin raffimer (Hemolink) in elective coronary artery bypass surgery. J Thorac Cardiovasc Surg 127 (2004) 79-86
54. Greenburg A., Kim H., and Hemolink Study Group. Use of an oxygen therapeutic as an adjunct to intraoperative autologous donation to reduce transfusion requirements in patients undergoing coronary artery bypass surgery. J Am Coll Surg 198 (2004) 373-383
55. Garrioch M., McClure J., and Wildsmith J. Haemodynamic effects of diaspirin crosslinked haemoglobin (DCLHb) given before abdominal aortic aneurysm surgery. Br J Anaesth 83 (1999) 702-707
56. Bloomfield E., Rady M., and Esfandiari S. A prospective trial of diaspirin-linked hemoglobin solution in patients after elective repair of abdominal aortic aneurysm. Mil Med 169 (2004) 546-550
57. Olofsson C., Ahl T., Johansson T., et al. A multicenter clinical study of the safety and activity of maleimide-polyethylene glycol-modified Hemoglobin (Hemospan) in patients undergoing major orthopaedic surgery. Anesthesiology 105 (2006) 1153-1163
58. Jahr J.S., Mackenzie C., Pearce L.B., et al. vHBOC-201 as an alternative to blood transfusion: efficacy and safety evaluation in a multicenter phase III trial in elective orthopedic surgery. J Trauma 64 (2008) 1484-1497
59. Natanson C., Kern S., Lurie P., et al. Cell-free hemoglobin-based blood substitutes and risk of myocardoial infarction and death: a meta-analysis. JAMA 299 (2008) 2304-2312
60. Lam C., Tyml K., Martin C., et al. Microvascular perfusion is impaired in a rat model of normotensive sepsis. J Clin Invest 94 (1994) 2077-2083
61. Sielenkämper A.W., Chin-Yee I.H., Martin C., et al. Diaspirin crosslinked hemoglobin improves systemic oxygen uptake in oxygen-supply dependent septic rats. Am J Respir Crit Care Med 156 (1997) 1066-1072
62. Creteur J., Zhang H., De Backer D., et al. Diaspirin cross-linked hemoglobin improves oxygen extraction capabilities in endotoxic shock. J Appl Physiol 89 (2000) 1437-1444
63. Wong H.R., Carcillo J.A., Burckart G., et al. Increased serum nitrite and nitrate concentrations in children with the sepsis syndrome. Crit Care Med 23 (1995) 835-842
64. Gomez-Jimenez J., Salgado A., Mourelle M., et al. l-arginine: nitric oxide pathway in endotoxemia and human septic shock. Crit Care Med 23 (1995) 253-258
65. Szabo C. Alterations in nitric oxide production in various forms of circulatory shock. New Horiz 3 (1995) 2-32
66. Vincent J.L., Preiser J.C., and Zhang H. Blocking the effects of nitric oxide in septic shock. In: Fink M.P., and Payen D. (Eds). Role of nitric oxide in septic shock-update in intensive care and emergency medicine Vol 24 (1995), Springer-Verlag, Berlin 253-273
67. Lopez A., Lorente J.A., Steingrub J., et al. Multiple-center, randomized, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 32 (2004) 21-30
68. Bone H.G., Waurick R., Van Aken H., et al. Comparison of the hemodynamic effects of nitric oxide synthase inhibition and nitric oxide scavenging in endotoxemic sheep. Intensive Care Med 24 (1998) 48-54
69. Matheson-Urbaitis B., Lu Y.S., Fronticelli C., et al. Renal and systemic-hemodynamic response to isovolemic exchange transfusion with hemoglobin cross-linked with bis (3, 5-dibromosalicyl) fumarate or albumin. J Lab Clin Med 126 (1995) 250-260
70. Heneka M.T., Löschmann P.A., and Osswald H. Polymerized hemoglobin restores cardiovascular and kidney function in endotoxin-induced shock in the rat. J Clin Invest 99 (1997) 47-54
71. Neviere R., Sielenkamper A., Pitt M., et al. Diaspirin crosslinked hemoglobin prevents endotoxin induced myocardial contractile dysfunction in an isolated and perfused rat heart model. Am J Respir Crit Care Med 155 (1997) A926 [abstract]
72. Cooper A., Ellis C., Lin H.Y., et al. Effect of diaspirin crosslinked hemoglobin (DCLHB) treatment on myocardial blood flow heterogeneity in septic sheep. Am J Respir Crit Care Med 155 (1997) A926 [abstract]
73. Kinasewitz G.T., Imm A., Steingrub J.S., et al. Multi-center, randomized, placebo-controlled study of the nitric oxide scavenger pyridoxalated hemoglobin polyoxyethylene in distributive shock. Crit Care Med 36 (2008) 1999-2007
74. Lee J.T., Arenholz D.H., Nelson R.D., et al. Mechanisms of the adjuvant effect of hemoglobin in experimental peritonitis V: the significance of the coordinated iron component. Surgery 86 (1979) 41-47
75. Kim Y.M., Yamazaki I., and Piette L.H. The effect of haemoglobin, hematin and iron on neutrophil inactivation in superoxide generating systems. Arch Biochem Biophys 309 (1994) 308-314
76. Griffiths E., Cortes A., Gilbert N., et al. Haemoglobin-based blood substitutes and sepsis. Lancet 345 (1995) 158-160
77. Su D., Roth R.I., and Levin J. Hemoglobin infusion augments the tumor necrosis factor response to bacterial endotoxin (lipopolysaccharide) in mice. Crit Care Med 27 (1999) 771-778
78. Sherry B.A., Alava G., Tracey K.J., et al. Malaria-specific metabolite hemozoin mediates the release of several potent endogenous pyrogens (TNF, MIP-1α and MIP-1β) in vitro, and altered thermoregulation in vivo. J Inflamm 45 (1995) 85-96
79. McFaul S.J., Bowman P.D., Villa V.M., et al. Hemoglobin stimulates mononuclear cells to release interleukin-8 and tumor necrosis factor α. Blood 84 (1994) 3175-3181
80. Carrillo E.H., Gordon L.E., Richardson J.D., et al. Free hemoglobin enhances tumor necrosis factor-alpha production in isolated human monocytes. J Trauma 52 (2002) 449-452
81. Rabinovici R., Rudolph A.S., Vernick J., et al. Lyophilized liposome encapsulated hemoglobin: evaluation of hemodynamic, biochemical, and hematologic responses. Crit Care Med 22 (1994) 480-485
82. Rudolph A.S., Cliff R., Kwasiborski V., et al. Liposome-encapsulated hemoglobin modulates lipopolysaccharide-induced tumor necrosis factor-α production in mice. Crit Care Med 25 (1997) 460-468
83. Chappell J.E., McBride W.J., and Shackford S.R. Diaspirin cross-linked hemoglobin resuscitation improves cerebral perfusion after head injury and shock. J Trauma 41 (1996) 781-788
84. Bowes M.P., Burhop K.E., and Zivin J.A. Diaspirin cross-linked hemoglobin improves neurological outcome following reversible but not irreversible CNS ischemia in rabbits. Stroke 25 (1994) 2253-2257
85. Cole D.J., Schell R.M., Drummond J.C., et al. Focal cerebral ischemia in rats: effect of hemodilution with α-α cross-linked hemoglobin on brain injury. Can J Neurol Sci 20 (1993) 30-36
86. Saxena R., Wijnhoud A.D., Carton H., et al. Controlled safety study of a hemoglobin-based oxygen carrier, DCLHb, in acute ischemic stroke. Stroke 30 (1999) 993-996
87. George I., Yi G., Schulman A., et al. A polymerized bovine haemoglobin oxygen carrier preserves regional myocardial function and reduces infarct size after acute myocardial ischemia. Am J Physiol Heart Circ Physiol 291 (2006) H1126-H1137
88. Burmeister M., Rempf C., Standl T., et al. Effect of prophylactic or therapeutic application of bovine haemoglobin HBOC-200 on ischaemia-reperfusion injury following acute coronary ligature in rats. Br J Anaesth 95 (2005) 737-745
89. Caswell J., Strange M., Rimmer D., et al. A novel hemoglobin-based blood substitute protects against myocardial reperfusion injury. Am J Physiol Heart Circ Physiol 288 (2005) H1796-H1801
90. Raff J.P., Dobson C.E., and Tsai H. Transfusion of polymerized human haemoglobin in a patient with severe sickle-cell anaemia. Lancet 60 (2002) 464-465
91. Lanzkron S., Moliterno A.R., Norris E.J., et al. Polymerized human Hb use in acute chest syndrome: a case report. Transfusion 42 (2002) 1422-1426
92. Gonzalez P., Hackney A.C., Jones S., et al. A phase I/II study of polymerized bovine hemoglobin in adult patients with sickle. J Investig Med 45 (1997) 258-264